Oxelumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Oxelumab
Monoclonal antibody
Type Whole antibody
Source Human
Target OX-40 ligand
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
Chemical and physical data
Formula C6424H9920N1704O2014S42
Molar mass 144.6 kg/mol
 NYesY (what is this?)  (verify)

Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]

Oxelumab was developed by Genentech and co-developed by Roche.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab" (PDF). American Medical Association.